Vir Biotechnology VIR SEC Filings

NASDAQ VIR
$11.42 -0.03 (-0.26%)
As of: Sep 4, 2026 · 12:49 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Vir Biotechnology, Inc. (VIR) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index